Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis

• Váldodahkkit: Yandan Zhou (Dahkki), Min Xu (Dahkki), Wei Gong (Dahkki), Xiaoming Kang (Dahkki), Renzhong Guo (Dahkki), Jie Wen (Dahkki), Dinggang Zhou (Dahkki), Manjing Wang (Dahkki), Dazhi Shi (Dahkki), Qiancheng Jing (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi Limited, 2022-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background. Allergic rhinitis (AR) is a highly heterogeneous disease, and allergen-specific immunotherapy (AIT) is an effective treatment. This study aims to evaluate the circulating mas-related G protein-coupled receptor-X2 (MRGPRX2) and matrix metalloproteinase-12 (MMP-12) levels in evaluating dis...